Edgewise Therapeutics Inc (EWTX)
Healthcare
Biotechnology
38.40 $
-6.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Edgewise Therapeutics Inc (EWTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 62.4% of the shares are freely tradable; institutional investors hold 113.9%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
113.9%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.5%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
62.4%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
13.1%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
108Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Orbimed Advisors, LLC | 14.42 | 15,518,492 | +0.0 | 03/31/2026 |
| RA Capital Management, LLC | 9.69 | 10,428,437 | +0.0 | 03/31/2026 |
| Paradigm Biocapital Advisors LP | 6.85 | 7,365,038 | +12.6 | 03/31/2026 |
| Baker Bros Advisors LP | 6.11 | 6,575,940 | +0.0 | 03/31/2026 |
| BlackRock Inc | 6.02 | 6,472,991 | -2.4 | 03/31/2026 |
| HHG PLC | 5.50 | 5,915,556 | +29.5 | 03/31/2026 |
| Novo A/S | 4.97 | 5,350,000 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 4.53 | 4,871,624 | +1.4 | 12/31/2025 |
| Driehaus Capital Management LLC | 4.16 | 4,477,942 | +6.8 | 03/31/2026 |
| Siren, L.L.C. | 4.12 | 4,430,263 | -2.2 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.